• Norsk
  • English

Tweets

Svein Stølen @sveinstlen Follow Kunnskap tas i bruk ⁦⁩ ! Må bare glede oss og heie -og fortsette å bygge en kultur for innovasjon & entrepr… https://t.co/u5fjZcr3Sg 3 months 1 week ago Reply Retweet Favorite
OsloCancerCluster @OsloCancer Follow Incredible to see our member featured in . A great example of how Norwegian resear… https://t.co/zO39wFtMOU 3 months 1 week ago Reply Retweet Favorite
Inven2as @Inven2as Follow I vår bransje må man satse på å være best i verden, sier Agnete Fredriksen, gründer av vårt spin-out selskap Vaccib… https://t.co/ZafBPIPA4o 3 months 1 week ago Reply Retweet Favorite
Hanne M Kristensen @HanneMKris Follow Oslo, Norge, Verden: ‘I vår bransje må man satse på å være best i verden.’ , gründer og vitenskapelig… https://t.co/5dB8zUxThj 3 months 1 week ago Reply Retweet Favorite
Ole Kr Hjelstuen @OKHjelstuen Follow Vaccibody det mest verdifulle biotek-selskapet i Norge nå. ⁦⁩ sin viktige rolle fint fortalt i ⁦https://t.co/SGnyguGQdW 3 months 1 week ago Reply Retweet Favorite
Inven2as @Inven2as Follow RT : Last week, we had a speed-dating session in our Incubator. Watch what happened in the video below!… https://t.co/ROAghKPpsY 3 months 2 weeks ago Reply Retweet Favorite
OsloCancerCluster @OsloCancer Follow Last week, we had a speed-dating session in our Incubator. Watch what happened in the video below!… https://t.co/ROAghKPpsY 3 months 2 weeks ago Reply Retweet Favorite
The Lab of Adaptive Immunity and Homeostasis @AndersenJT Follow Always fun to talk at the School of Health Innovation! And so many interesting questions. https://t.co/ztcikkLc3p 3 months 3 weeks ago Reply Retweet Favorite
Inven2as @Inven2as Follow RT : Store framskritt i bruk av kunstig intelligens til å stille diagnoser i dagens ⁦⁩ ⁦… https://t.co/RjQeMKgoy4 3 months 3 weeks ago Reply Retweet Favorite
Inven2as @Inven2as Follow RT : We can have 2 or 3 more «Algetas» in the next 5 years from the companies already built, says ⁦⁩ at… https://t.co/x87caShYyC 3 months 3 weeks ago Reply Retweet Favorite
Inven2as @Inven2as Follow RT : Mangel på godkjente legemidler og ulik førstelinjebehandling med resten av Europa er et stort hinder for nye, klini… https://t.co/VpGXe8UFHj 3 months 3 weeks ago Reply Retweet Favorite
The Lab of Adaptive Immunity and Homeostasis @AndersenJT Follow I dag presenterte Simone Mester sin forskning på den store inspirasjonsdagen Jenter og teknologi 2020 på Chateau Ne… https://t.co/YVuLY2HwZ5 3 months 3 weeks ago Reply Retweet Favorite
Ole Kr Hjelstuen @OKHjelstuen Follow Norway can be a significant player in Life Science globally, and the ⁦⁩ is investing heavily in infrastruct… https://t.co/S6VhiMOQMS 3 months 3 weeks ago Reply Retweet Favorite
Ole Kr Hjelstuen @OKHjelstuen Follow We can have 2 or 3 more «Algetas» in the next 5 years from the companies already built, says ⁦⁩ at… https://t.co/x87caShYyC 3 months 3 weeks ago Reply Retweet Favorite
Ole Kr Hjelstuen @OKHjelstuen Follow Mangel på godkjente legemidler og ulik førstelinjebehandling med resten av Europa er et stort hinder for nye, klini… https://t.co/VpGXe8UFHj 3 months 3 weeks ago Reply Retweet Favorite
Ole Kr Hjelstuen @OKHjelstuen Follow Kliniske studier må være en integrert del av pasientbehandling, sier ⁦⁩ ⁦⁩ på… https://t.co/xWR4vAe4Uc 3 months 3 weeks ago Reply Retweet Favorite
Inven2as @Inven2as Follow RT : Vaccibody vokser videre. God utvikling i resten av norsk biotek også. ⁦⁩ idag. ⁦⁩… https://t.co/H86R6qaWj1 3 months 3 weeks ago Reply Retweet Favorite
Ole Kr Hjelstuen @OKHjelstuen Follow Vaccibody vokser videre. God utvikling i resten av norsk biotek også. ⁦⁩ idag. ⁦⁩… https://t.co/H86R6qaWj1 3 months 3 weeks ago Reply Retweet Favorite
Inven2as @Inven2as Follow Partnership for Life 2020 starts tomorrow. Use this opportunity to meet with potential partners. People have allrea… https://t.co/G7MUIxZlpt 3 months 3 weeks ago Reply Retweet Favorite
Ole Kr Hjelstuen @OKHjelstuen Follow Real World Evidence in the Nordics, conference at the National Cancer Hospital ⁦⁩ opened by ⁦… https://t.co/ikqQOoblr9 3 months 3 weeks ago Reply Retweet Favorite

Pages